Stocks and InvestingStocks and Investing
Thu, July 22, 2021
Wed, July 21, 2021
Tue, July 20, 2021
Mon, July 19, 2021
Fri, July 16, 2021

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $35 on, Jul 16th, 2021


Published on 2024-10-27 17:13:27 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $36 to $35 on, Jul 16th, 2021.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Yun Zhong of "Berenberg" Downgraded from Strong Buy to Hold and Held Target at $35 on, Thursday, July 1st, 2021


This is the rating of the analyst that currently disagrees with Matthew


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $72 on, Monday, March 29th, 2021